Stay updated on Itolizumab in Uncontrolled Asthma Clinical Trial
Sign up to get notified when there's something new on the Itolizumab in Uncontrolled Asthma Clinical Trial page.

Latest updates to the Itolizumab in Uncontrolled Asthma Clinical Trial page
- Check2 days agoChange DetectedThe page shows a new revision label (v3.6.5) indicating a software update to the page rendering, replacing the previous v3.6.4 revision.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4 in the page footer, indicating a minor system/documentation update. This does not alter trial details or participant information.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe study page revision label was updated from v3.6.2 to v3.6.3, indicating a new version of the page in the revision history.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page revision has been updated from v3.6.0 to v3.6.2, indicating a newer build of the study page. This is likely a routine maintenance or minor update rather than changes to the trial details.SummaryDifference0.0%

- Check60 days agoChange DetectedRecruitment status now shows that the study is not accepting participants, and new help/navigation sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') were added. Additionally, the 'Intervention/Treatment' header formatting was standardized by removing the extra space around the slash, and the revision tag was updated from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check67 days agoChange DetectedA new revision tag (v3.5.5) and recent update dates (May and June 2026) were added to the study record, indicating ongoing maintenance of the entry. The collaborator listing was updated by removing Equillium AUS Pty Ltd.SummaryDifference0.6%

Stay in the know with updates to Itolizumab in Uncontrolled Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Itolizumab in Uncontrolled Asthma Clinical Trial page.